Legence: Expecting A Bounce Back In 2027
Tigress Financial Maintains Buy on Legence, Raises Price Target to $130
Guggenheim Reiterates Buy on Legence, Maintains $115 Price Target
B of A Securities Maintains Buy on Legence, Raises Price Target to $116
These Analysts Revise Their Forecasts On Legence Following Q2 Results
BMO Capital Maintains Outperform on Legence, Raises Price Target to $105
BTIG Reiterates Buy on Legence, Lowers Price Target to $100
Legence Corp. (LGN) Q2 2026 Earnings Call Transcript
Legence Corp. 2026 Q2 - Results - Earnings Call Presentation
Legence Q2 EPS $0.17 Misses $0.33 Estimate, Sales $1.260B Beat $1.074B Estimate
Legence Sees Q3 Sales $1.225B-$1.275B vs $1.080B Est
Legence Raises FY2026 Sales Guidance from $4.100B-$4.300B to $4.700B-$4.800B vs $4.274B Est
Roth Capital Reiterates Buy on Legence, Maintains $120 Price Target
RBC Capital Maintains Outperform on Legence, Lowers Price Target to $101
Are Options Traders Betting on a Big Move in Legence Stock?
Guggenheim Maintains Buy on Legence, Raises Price Target to $115
Barclays Raises its Price Target on Legence (LGN)
Barclays Maintains Equal-Weight on Legence, Raises Price Target to $80
Legence: Growth Has More Visibility, Still Not Enough Margin Of Safety
Legence Announces Improved Term Loan Pricing on Credit Rating Upgrade
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.